118 related articles for article (PubMed ID: 28262199)
21. Hyponatremia in patients with systemic lupus erythematosus.
Il Shin J; Park SJ; Suh CH; Lee GH; Hur MW; Han SY; Kim DS; Kim JH
Sci Rep; 2016 May; 6():25566. PubMed ID: 27193532
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of coagulation disorders by thromboelastography in children with systemic lupus erythematosus.
Li Z; Xiao J; Song H; Chen Q; Han H; Li J; Zhang L; He Y; Wei M
Lupus; 2019 Feb; 28(2):181-188. PubMed ID: 30563423
[TBL] [Abstract][Full Text] [Related]
23. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus.
Chung CP; Oeser A; Solus J; Avalos I; Gebretsadik T; Shintani A; Linton MF; Fazio S; Stein CM
J Rheumatol; 2007 Sep; 34(9):1849-54. PubMed ID: 17659756
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients.
Qin B; Ma N; Tang Q; Wei T; Yang M; Fu H; Hu Z; Liang Y; Yang Z; Zhong R
Mod Rheumatol; 2016; 26(3):372-6. PubMed ID: 26403379
[TBL] [Abstract][Full Text] [Related]
26. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus.
Islam MN; Hossain M; Haq SA; Alam MN; Ten Klooster PM; Rasker JJ
Int J Rheum Dis; 2012 Feb; 15(1):62-8. PubMed ID: 22324948
[TBL] [Abstract][Full Text] [Related]
28. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus.
Jin T; Almehed K; Carlsten H; Forsblad-d'Elia H
Lupus; 2012 Mar; 21(3):310-8. PubMed ID: 22072025
[TBL] [Abstract][Full Text] [Related]
29. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.
Závada J; Uher M; Svobodová R; Olejárová M; Hušáková M; Ciferská H; Hulejová H; Tomčík M; Šenolt L; Vencovský J
Arthritis Res Ther; 2015 Nov; 17():341. PubMed ID: 26608564
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
[TBL] [Abstract][Full Text] [Related]
31. Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity.
Jacobi AM; Rohde W; Ventz M; Riemekasten G; Burmester GR; Hiepe F
Lupus; 2001; 10(8):554-61. PubMed ID: 11530997
[TBL] [Abstract][Full Text] [Related]
32. Serum human epididymis protein 4 is a predictor for developing nephritis in patients with systemic lupus erythematosus: A prospective cohort study.
Ren Y; Xie J; Lin F; Luo W; Zhang Z; Mao P; Zhong R; Liang Y; Yang Z
Int Immunopharmacol; 2018 Jul; 60():189-193. PubMed ID: 29747124
[TBL] [Abstract][Full Text] [Related]
33. Using combination of albumin to fibrinogen ratio and prognostic nutritional index model for predicting disease activity in patients with systemic lupus erythematosus.
Zhao H; Huang Z; Wang S; Fu P; Fu B; Guo Y; Li J; Luo Q
Lupus; 2024 Apr; 33(5):490-501. PubMed ID: 38457835
[No Abstract] [Full Text] [Related]
34. Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy.
Sakthiswary R; Suresh E
Lupus; 2014 Mar; 23(3):225-35. PubMed ID: 24399812
[TBL] [Abstract][Full Text] [Related]
35. The Chinese version of the SLEQOL is a reliable assessment of health-related quality of life in Han Chinese patients with systemic lupus erythematosus.
Jiang HZ; Lin ZG; Li HJ; -Du Q; -Tian W; Wang SY; Guan SQ; Mei YF
Clin Rheumatol; 2018 Jan; 37(1):151-160. PubMed ID: 29168029
[TBL] [Abstract][Full Text] [Related]
36. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients.
Keenan RT; Swearingen CJ; Yazici Y
Clin Exp Rheumatol; 2008; 26(5):814-9. PubMed ID: 19032813
[TBL] [Abstract][Full Text] [Related]
37. Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study.
Liang Y; Leng RX; Pan HF; Ye DQ
Med Sci Monit; 2017 May; 23():2543-2549. PubMed ID: 28548078
[TBL] [Abstract][Full Text] [Related]
38. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
[TBL] [Abstract][Full Text] [Related]
39. [Role of C-reactive protein in systemic lupus erythematosus].
Cengić M; Heljić B; Rasić S; Dilić M
Med Arh; 2002; 56(3):147-9. PubMed ID: 12378859
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment.
Tanaka E; Harigai M; Tanaka M; Kawaguchi Y; Hara M; Kamatani N
J Rheumatol; 2002 Feb; 29(2):282-7. PubMed ID: 11838845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
